A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)

Status:
Withdrawn

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

This study will evaluate the safety and efficacy of AG-014699 in diabetic patients

Phase 2

Pfizer

Rucaparib